Dynamic contrast
enhanced MRI perfusion is a useful
technique for assessment of glioma grading. This technique has been used in
the past for discrimination of low from high grade gliomas. This study
investigates the ability of DCE perfusion MRI to discriminate Grade II from
Grade III and Grade III from Grade IV gliomas. Various DCE pharmacokinetic
parameters were also analysed for their ability to distinguish the various
grades of gliomas.

This abstract and the presentation materials are available to members only;
a login is required.